Reports Library Publication
Insight Consumer Healthcare North America May / June 2026
26th June 2026 by CHC Insight
1. Analgesics OTC industry defends acetaminophen safety
2. MCP McCaughey Q&A Gbenga Ademo shares expert insight on retail in Canada
3. Switch Spotlight Differin Epiduo launched without prescription in USA
4. Innovation Round-up Supplement brands target skin health
5. News Review Unilever invests in new Global Innovation Centre
Order this report
Why buy this report?
"Our Analgesics Market Report looks at the strong collective response of the CHC industry and public health bodies to the Trump Administration’s unfounded attack on the safety of acetaminophen in September 2025, which helped to maintain consumer confidence in the essential ingredient. Elsewhere, we hope that readers enjoy the insightful Q&A with McCaughey’s Gbenga Ademo on the Canadian retail and analgesics sectors, while we also profile the big US switch news – the approval and launch of Differin Epiduo, the first OTC retinoid + benzoyl peroxide combination acne remedy."
Nicholas Hall